Comparison of the results between the PIP-18-treated and untreated SFs indicates that significant inhibition of gene expression was evident in human RA SF for MMP-1, -2, -3, -9, and sPLA2, but not for TIMP-1 and TIMP-2. The gene discussed is TIMP2; the disease is rheumatoid arthritis.